Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
NeuroOne Medical Technologies (NMTC)
NASDAQ:NMTC
RESEARCH TOOLSreports
NMTC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.55 - $1.59
Previous CloseN/A
Volume212.44K
Average Volume (3M)285.26K
Market Cap
$36.88M
Enterprise Value$28.42M
Total Cash (Recent Filing)$26.47K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.42
Next Earnings
Feb 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.46
Shares Outstanding30,857,924
10 Day Avg. Volume355,114
30 Day Avg. Volume285,260
Standard Deviation0.28
R-Squared0.01
Alpha-0.00808
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)10.67
Price to Cash Flow (P/CF)-3.50
P/FCF Ratio0.00
Enterprise Value/Market Cap0.77
Enterprise Value/Revenue8.23
Enterprise Value/Gross Profit26.33
Enterprise Value/Ebitda-2.37
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NeuroOne Medical Technologies News
PremiumCompany Announcements
NeuroOne Medical Technologies Shares Strategic Vision with Shareholders
PremiumCompany Announcements
NeuroOne Reports Record Revenue Boost in Q1 2025
PremiumCompany Announcements
NeuroOne Sees Revenue Surge Amid Strategic Partnership
Ownership Overview
12.96% Insiders
3.76% Mutual Funds
0.20% Other Institutional Investors
80.10% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NMTC FAQ
What was NeuroOne Medical Technologies’s price range in the past 12 months?
NeuroOne Medical Technologies lowest stock price was $0.55 and its highest was $1.59 in the past 12 months.
What is NeuroOne Medical Technologies’s market cap?
NeuroOne Medical Technologies’s market cap is $36.88M.
When is NeuroOne Medical Technologies’s upcoming earnings report date?
NeuroOne Medical Technologies’s upcoming earnings report date is Feb 18, 2025 which is in 20 days.
How were NeuroOne Medical Technologies’s earnings last quarter?
NeuroOne Medical Technologies released its earnings results on Dec 17, 2024. The company reported -$0.11 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.11.
Is NeuroOne Medical Technologies overvalued?
According to Wall Street analysts NeuroOne Medical Technologies’s price is currently Overvalued.
Does NeuroOne Medical Technologies pay dividends?
NeuroOne Medical Technologies does not currently pay dividends.
What is NeuroOne Medical Technologies’s EPS estimate?
NeuroOne Medical Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NeuroOne Medical Technologies have?
NeuroOne Medical Technologies has 30,857,924 shares outstanding.
What happened to NeuroOne Medical Technologies’s price movement after its last earnings report?
NeuroOne Medical Technologies reported an EPS of -$0.11 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.947%.
Which hedge fund is a major shareholder of NeuroOne Medical Technologies?
Currently, no hedge funds are holding shares in NMTC
---
NeuroOne Medical Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
NMTC Sentiment 100%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 10.4%
Last 30 Days ▼ 10.4%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-10.15%
12-Months-Change
Fundamentals
Return on Equity
-348.39%
Trailing 12-Months
Asset Growth
-33.68%
Trailing 12-Months
Company Description
NeuroOne Medical Technologies
NeuroOne Medical Technologies Corp. operates as a medical technology company. It focuses on development and commercialization of thin film electrode technology for cEEG and sEEG recording, brain stimulation and ablation solutions for patients suffering from brain related disorders. The company was founded on August 20, 2009 and is headquartered in Minnetonka, MN.
---
NMTC Earnings Call
Q4 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The call showcased significant achievements such as FDA clearance, strategic partnerships, and strong projected growth, but also highlighted challenges with current revenue decline and increased net losses. However, the focus on future growth and technological advancements provides a positive outlook.Read More>---
NMTC Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering NMTC
1 Year
1 Year Success Rate
2/5 ratings generated profit
1 Year Average Return
-13.24%
reiterated a buy rating 12 months ago
Copying Ben Haynor's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -13.24% per trade.
---